Which method is safer? study tests how to stop vasopressin in sepsis
NCT ID NCT07067866
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the best way to stop the blood pressure medication vasopressin in people with septic shock. It compares slowly reducing the dose versus stopping it all at once. The goal is to see which method causes fewer dangerous drops in blood pressure. The study involves 82 adults in the ICU who are already stable on both norepinephrine and vasopressin.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Nossa Senhora da Conceição
RECRUITINGPorto Alegre, Rio Grande do Sul, 91350200, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood markers may foretell brain fog after sepsis
- Can tracking immune chaos in sepsis reveal new treatment targets?
- Blood clot score may predict organ damage in septic shock
- Could a key hormone be missing in septic shock?
- Could a simple mineral cut the need for powerful blood-pressure drugs in septic shock?
- Blood filter could shield vessels in septic shock